| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
Cerivastatin in primary hyperlipidemia: a multicenter analysis of efficacy and safety
|
Stein, Evan
|
|
1998
|
82 |
4S2 |
p. 40J-46J
nvt p.
|
artikel
|
| 2 |
Cerivastatin in the treatment of mixed hyperlipidemia: the right study
|
Farnier, Michel
|
|
1998
|
82 |
4S2 |
p. 47J-51J
nvt p.
|
artikel
|
| 3 |
Clinical efficacy and safety of cerivastatin in the treatment of heterozygous familial hypercholesterolemia
|
Mabuchi, Hiroshi
|
|
1998
|
82 |
4S2 |
p. 52J-55J
nvt p.
|
artikel
|
| 4 |
Clinical efficacy and safety of cerivastatin: summary of pivotal Phase IIb/III studies
|
Davignon, Jean
|
|
1998
|
82 |
4S2 |
p. 32J-39J
nvt p.
|
artikel
|
| 5 |
Clinical efficacy of cerivastatin: phase IIa dose-ranging and dose-scheduling studies
|
Hunninghake, Donald B
|
|
1998
|
82 |
4S2 |
p. 26J-31J
nvt p.
|
artikel
|
| 6 |
Current and future treatment of hyperlipidemia: the role of statins
|
Farnier, Michel
|
|
1998
|
82 |
4S2 |
p. 3J-10J
nvt p.
|
artikel
|
| 7 |
Introduction
|
Thompson, Gilbert R.
|
|
1998
|
82 |
4S2 |
p. 1J-2J
nvt p.
|
artikel
|
| 8 |
Preclinical and clinical pharmacology of cerivastatin
|
Bischoff, Hilmar
|
|
1998
|
82 |
4S2 |
p. 18J-25J
nvt p.
|
artikel
|
| 9 |
Preclinical safety evaluation of cerivastatin, a novel HMG-CoA reductase inhibitor
|
Keutz, Eckhard von
|
|
1998
|
82 |
4S2 |
p. 11J-17J
nvt p.
|
artikel
|
Tijdschrift beschrijving